Metabolomics Workbench : NIH Data Repository

Lipid composition heatmap for Study ST001202

Select 2 experimental conditions (at least one from A and at least one from B) to compare lipid profiles.

Group A	Combined factors (this analysis)	Group B
	cell_type:iRBC \| treatment:DHA \| treatment_duration_(h):-
	cell_type:iRBC \| treatment:DHA \| treatment_duration_(h):1.5
	cell_type:iRBC \| treatment:DHA \| treatment_duration_(h):3
	cell_type:iRBC \| treatment:DHA \| treatment_duration_(h):6
	cell_type:iRBC \| treatment:DMSO \| treatment_duration_(h):-
	cell_type:iRBC \| treatment:DMSO \| treatment_duration_(h):1.5
	cell_type:iRBC \| treatment:DMSO \| treatment_duration_(h):3
	cell_type:iRBC \| treatment:DMSO \| treatment_duration_(h):6
	cell_type:iRBC \| treatment:DMSO \| treatment_duration_(h):9
	cell_type:iRBC \| treatment:OZ277 \| treatment_duration_(h):-
	cell_type:iRBC \| treatment:OZ277 \| treatment_duration_(h):3
	cell_type:iRBC \| treatment:OZ277 \| treatment_duration_(h):6
	cell_type:iRBC \| treatment:OZ277 \| treatment_duration_(h):9
	cell_type:iRBC \| treatment:OZ439 \| treatment_duration_(h):-
	cell_type:iRBC \| treatment:OZ439 \| treatment_duration_(h):3
	cell_type:iRBC \| treatment:OZ439 \| treatment_duration_(h):6
	cell_type:iRBC \| treatment:OZ439 \| treatment_duration_(h):9
	cell_type:unRBC \| treatment:DHA \| treatment_duration_(h):-
	cell_type:unRBC \| treatment:DHA \| treatment_duration_(h):1.5
	cell_type:unRBC \| treatment:DHA \| treatment_duration_(h):3
	cell_type:unRBC \| treatment:DHA \| treatment_duration_(h):6
	cell_type:unRBC \| treatment:DMSO \| treatment_duration_(h):-
	cell_type:unRBC \| treatment:DMSO \| treatment_duration_(h):1.5
	cell_type:unRBC \| treatment:DMSO \| treatment_duration_(h):3
	cell_type:unRBC \| treatment:DMSO \| treatment_duration_(h):6
	cell_type:unRBC \| treatment:DMSO \| treatment_duration_(h):9
	cell_type:unRBC \| treatment:OZ277 \| treatment_duration_(h):-
	cell_type:unRBC \| treatment:OZ277 \| treatment_duration_(h):3
	cell_type:unRBC \| treatment:OZ277 \| treatment_duration_(h):6
	cell_type:unRBC \| treatment:OZ277 \| treatment_duration_(h):9
	cell_type:unRBC \| treatment:OZ439 \| treatment_duration_(h):-
	cell_type:unRBC \| treatment:OZ439 \| treatment_duration_(h):3
	cell_type:unRBC \| treatment:OZ439 \| treatment_duration_(h):6
	cell_type:unRBC \| treatment:OZ439 \| treatment_duration_(h):9
Select a lipid RefMet sub class:

Lipid sub classes in this study	Number in study
Acyl carnitines	16
Cer	4
LPC	7
LPE	7
O-LPC	3
O-LPE	1
O-PE	11
O-PI	1
PA	6
PC	15
PE	13
PG	5
PI	5
PS	15
Saturated FA	13
SM	19
TAG	1
Unsaturated FA	10

Group A	Combined factors (this analysis)	Group B
	cell_type:iRBC \| treatment:DHA \| treatment_duration_(h):-
	cell_type:iRBC \| treatment:DHA \| treatment_duration_(h):1.5
	cell_type:iRBC \| treatment:DHA \| treatment_duration_(h):3
	cell_type:iRBC \| treatment:DHA \| treatment_duration_(h):6
	cell_type:iRBC \| treatment:DMSO \| treatment_duration_(h):-
	cell_type:iRBC \| treatment:DMSO \| treatment_duration_(h):1.5
	cell_type:iRBC \| treatment:DMSO \| treatment_duration_(h):3
	cell_type:iRBC \| treatment:DMSO \| treatment_duration_(h):6
	cell_type:iRBC \| treatment:DMSO \| treatment_duration_(h):9
	cell_type:iRBC \| treatment:OZ277 \| treatment_duration_(h):-
	cell_type:iRBC \| treatment:OZ277 \| treatment_duration_(h):3
	cell_type:iRBC \| treatment:OZ277 \| treatment_duration_(h):6
	cell_type:iRBC \| treatment:OZ277 \| treatment_duration_(h):9
	cell_type:iRBC \| treatment:OZ439 \| treatment_duration_(h):-
	cell_type:iRBC \| treatment:OZ439 \| treatment_duration_(h):3
	cell_type:iRBC \| treatment:OZ439 \| treatment_duration_(h):6
	cell_type:iRBC \| treatment:OZ439 \| treatment_duration_(h):9
	cell_type:unRBC \| treatment:DHA \| treatment_duration_(h):-
	cell_type:unRBC \| treatment:DHA \| treatment_duration_(h):1.5
	cell_type:unRBC \| treatment:DHA \| treatment_duration_(h):3
	cell_type:unRBC \| treatment:DHA \| treatment_duration_(h):6
	cell_type:unRBC \| treatment:DMSO \| treatment_duration_(h):-
	cell_type:unRBC \| treatment:DMSO \| treatment_duration_(h):1.5
	cell_type:unRBC \| treatment:DMSO \| treatment_duration_(h):3
	cell_type:unRBC \| treatment:DMSO \| treatment_duration_(h):6
	cell_type:unRBC \| treatment:DMSO \| treatment_duration_(h):9
	cell_type:unRBC \| treatment:OZ277 \| treatment_duration_(h):-
	cell_type:unRBC \| treatment:OZ277 \| treatment_duration_(h):3
	cell_type:unRBC \| treatment:OZ277 \| treatment_duration_(h):6
	cell_type:unRBC \| treatment:OZ277 \| treatment_duration_(h):9
	cell_type:unRBC \| treatment:OZ439 \| treatment_duration_(h):-
	cell_type:unRBC \| treatment:OZ439 \| treatment_duration_(h):3
	cell_type:unRBC \| treatment:OZ439 \| treatment_duration_(h):6
	cell_type:unRBC \| treatment:OZ439 \| treatment_duration_(h):9
Select a lipid RefMet sub class: